Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

50.8K
Overview
50.8K
Development of Immunocompetence01:22

Development of Immunocompetence

661
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
661
Cancer Vaccines01:30

Cancer Vaccines

867
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
867
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

820
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
820
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Cross-reactivity00:42

Cross-reactivity

32.6K
Overview
32.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel antivenoms bite back.

Nature biotechnology·2026
Same author

At last, a pipeline for treating kidney disease.

Nature medicine·2026
Same author

The Long Journey to an Artificial Pancreas: This biotech could transform type 1 diabetes care.

Scientific American·2025
Same author

This Striking Blue Made Pigment History. Could Red Be Next?

ACS central science·2025
Same author

Too easy to swallow.

Nature medicine·2025
Same author

How a mysterious epidemic of kidney disease is killing thousands of young men.

Nature·2025

Related Experiment Video

Updated: Dec 18, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.6K

Race for a vaccine.

Carrie Arnold1

  • 1is a science writer based in Virginia. Follow her @edbites.

New Scientist (1971)
|June 11, 2020
PubMed
Summary
This summary is machine-generated.

New vaccine delivery techniques are being explored to combat the worsening coronavirus pandemic. This research investigates the feasibility of rapidly developing and distributing vaccines to meet global health demands.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.1K

Related Experiment Videos

Last Updated: Dec 18, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.6K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.1K

Area of Science:

  • Vaccinology
  • Epidemiology
  • Public Health

Background:

  • The escalating coronavirus pandemic necessitates rapid vaccine development and deployment.
  • Traditional vaccine development timelines are insufficient for current global health emergencies.

Purpose of the Study:

  • To explore novel techniques for accelerated vaccine delivery.
  • To assess the feasibility of achieving record-time vaccine deployment.

Main Methods:

  • Review of emerging vaccine technologies.
  • Analysis of logistical challenges in mass vaccination campaigns.
  • Evaluation of regulatory pathways for expedited vaccine approval.

Main Results:

  • Identification of promising innovative vaccine delivery platforms.
  • Assessment of potential bottlenecks in manufacturing and distribution.
  • Preliminary evaluation of the efficacy and safety of accelerated approaches.

Conclusions:

  • Accelerated vaccine delivery is technically feasible but faces significant logistical and regulatory hurdles.
  • Continued research and international collaboration are crucial for timely pandemic response.